Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression (Q44277460)
Jump to navigation
Jump to search
scientific article published in February 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression |
scientific article published in February 2003 |
Statements
1 reference
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression (English)
1 reference
F R Appelbaum
1 reference
C L Willman
1 reference
D L Stirewalt
1 reference
R A Zager
1 reference
D E Banker
1 reference
1 February 2003
1 reference
1 reference
Identifiers
1 reference